Clinical HIV epidemiology and comorbidity – Christina Carlander Research group

Our research focuses on improving health outcomes for people living with HIV, with particular emphasis on cancer prevention, screening, and risk prediction. Through innovative use of Swedish national health registers and quality databases, we study various aspects of HIV care. Our work combines traditional epidemiological methods with cutting-edge approaches such as machine learning and prospective biomarker studies to develop practical clinical tools for individualized patient care.

Part of the:

Ongoing Projects

HIVigilant

Development of machine learning-based prediction models for cancer risk in people with HIV, aiming to create a clinical tool for individualized cancer screening. This project addresses the critical need for HIV-specific screening guidelines beyond cervical cancer.

SANCA Study

A prospective study on anal cancer screening in women with HIV, investigating the feasibility and effectiveness of anal cancer screening , assessment of new biomarkers, and risk stratification methods. Including women from age 45 attending HIV care at Karolinska University Hospital, South Hospital and Sahlgrenska University Hospital.

COSMOHS 

COSMOHS (Cohort Study on Morbidity and HIV in Sweden) is a longitudinal population-based study linking national Swedish demographic and health registers to analyze differences in health outcomes between people living with HIV and those without HIV. By examining epidemiology, late HIV presentation, comorbidities, and quality of life, this study aims to provide comprehensive insights into factors affecting long-term health outcomes in the Swedish population living with HIV.